Research Title: Triple Therapy — PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration

Sponsor: Bay Area Retina Associates

Principal Investigator: Atul Sharma, M.D.

Description: The purpose of this study is to compare triple therapy using Photodynamic therapy, intravitreal Dexamethasone and intravitreal Ranibizumab injections versus monotherapy with intravitreal Ranibizumab alone for the treatment of Age-Related Macular Degeneration.

Start Date: October 2006

Recruitment: Completed

Project Personnel: Leslie Marcus, CCRC

Location(s): Riverdale; 155 Medical Way, Suite E, Riverdale, GA 30274